Health Condition 1: L649- Androgenic alopecia, unspecified Health Condition 2: L989- Disorder of the skin and subcutaneous tissue, unspecified Health Condition 3: O- Medical and Surgical
Conditions
Interventions
Intervention1: Group receiving supraorbital and supratrochlear nerve blocks: The supraorbital and supratrochlear nerve block will be performed with 1.5ml of 0.5% bupivacaine bilaterally(total 3ml) us
Sponsors
Amrita Institute of Medical Sciences
Eligibility
Inclusion criteria
Inclusion criteria: All male patients between 18 to 60 years undergoing hair transplants under local anesthesia
Exclusion criteria
Exclusion criteria: 1. Female patients 2. Allergic to local anesthetic
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To compare the pain on injection while performing the supraorbital and supratrochlear nerve blocks vs. frontal nerve block.Timepoint: Immediately after performing block | — |
Secondary
| Measure | Time frame |
|---|---|
| Changes in heart rate and blood pressureTimepoint: During performance of block | — |
Countries
India
Contacts
Public ContactDr Sundeep Vijayaraghavan
Amrita Institute of Medical Sciences
Outcome results
None listed